Season 25 Episode 139
Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.
CME information and select publications here.
Published on 2 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate